Paris
France
8
2022-08-11
3
2024-07-30
These are the the leading inventors for applications assigned to VAXON BIOTECH:
VAXON BIOTECH based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Combination of Markers for Predicting the Response to Vx-001
#2 | 2020-03-12Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker Patient
#3 | 2020-03-12 ✅ Patent 12,048,737 granted on 2024-07-30Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing tert
#4 | 2019-05-23Method for Emulsifying a Triepitope Peptide with Montanide and Kits for Performing the Same
#5 | 2017-06-08Immunogenic Polypeptide Composed of HLA-B7 Restricted Tumor Antigen-Derived Optimized Cryptic Peptides, and Uses Thereof
#6 | 2017-01-05METHOD FOR EMULSIFYING A TRIEPITOPE PEPTIDE WITH MONTANIDE AND KITS FOR PERFORMING THE SAME
#7 | 2012-06-07 ✅ Patent 10,024,868 granted on 2018-07-17Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy
#8 | 2012-04-05 ✅ Patent 8,900,600 granted on 2014-12-02Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy
117537 ⎘